Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
St. Jude Medical Center
1960
mi
from 43215
Fullerton, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
St. Jude Medical Center
1960
mi
from 43215
Fullerton, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Moores UCSD Cancer Center
1950
mi
from 43215
La Jolla, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Moores UCSD Cancer Center
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Stanford Cancer Institute
2102
mi
from 43215
Palo Alto, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Stanford Cancer Institute
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Innovative Clinical Research Institute, LLC
1961
mi
from 43215
Whittier, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Innovative Clinical Research Institute, LLC
1961
mi
from 43215
Whittier, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Advanced Medical Specialists
993
mi
from 43215
Miami, FL
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Advanced Medical Specialists
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Lewis Hall Singletary Oncology Center
632
mi
from 43215
Thomasville, GA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Lewis Hall Singletary Oncology Center
632
mi
from 43215
Thomasville, GA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Karmanos Cancer Institute
164
mi
from 43215
Detroit, MI
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Karmanos Cancer Institute
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
New Mexico Cancer Care Alliance
1327
mi
from 43215
Albuquerque, NM
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
New Mexico Cancer Care Alliance
1327
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Oncology Hematology Care
86
mi
from 43215
Cincinnati, OH
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Oncology Hematology Care
86
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Northwest Cancer Specialist, P.C
1931
mi
from 43215
Portland and Yualatin, OR
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Northwest Cancer Specialist, P.C
1931
mi
from 43215
Portland and Yualatin, OR
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Albert Einstein Cancer Center
416
mi
from 43215
Philadelphia, PA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Albert Einstein Cancer Center
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Tennessee Oncology-Chattanooga
361
mi
from 43215
Chattanooga, TN
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Tennessee Oncology-Chattanooga
361
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Tennessee Oncology PPLC SCRI
332
mi
from 43215
Nashville, TN
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Tennessee Oncology PPLC SCRI
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology
925
mi
from 43215
Bedford and Grapevine, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology
925
mi
from 43215
Bedford and Grapevine, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology - Dallas
911
mi
from 43215
Dallas, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology - Dallas
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology - Longview and Tyler
862
mi
from 43215
Longview and Tyler, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology - Longview and Tyler
862
mi
from 43215
Longview and Tyler, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Cancer Care Center of South Texas-HOAST
1138
mi
from 43215
New Braunfels and San Antonio, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Cancer Care Center of South Texas-HOAST
1138
mi
from 43215
New Braunfels and San Antonio, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Brooke Army Medical Center
1134
mi
from 43215
San Antonio, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Brooke Army Medical Center
1134
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Scott and White Healthcare
1018
mi
from 43215
Temple, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Scott and White Healthcare
1018
mi
from 43215
Temple, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
University of TX Health Science Center at Tyler
862
mi
from 43215
Tyler, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
University of TX Health Science Center at Tyler
862
mi
from 43215
Tyler, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Northwest Cancer Specialist
2024
mi
from 43215
Vancouver, WA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Northwest Cancer Specialist
2024
mi
from 43215
Vancouver, WA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center
1970
mi
from 43215
Los Angeles, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Rocky Mountain Cancer Centers
1163
mi
from 43215
Multiple Locations, CO
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Rocky Mountain Cancer Centers
1163
mi
from 43215
Multiple Locations, CO
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Montefiore Medical Center
485
mi
from 43215
The Bronx, NY
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Montefiore Medical Center
485
mi
from 43215
The Bronx, NY
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Oncology Hematology Consultants PA
938
mi
from 43215
Fort Worth, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Oncology Hematology Consultants PA
938
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology - Forth Worth
938
mi
from 43215
Fort Worth, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology - Forth Worth
938
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Virginia Oncology Associates
434
mi
from 43215
Multiple Locations, VA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Virginia Oncology Associates
434
mi
from 43215
Multiple Locations, VA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Royal North Shore Hospital
9456
mi
from 43215
St Leonards,
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Royal North Shore Hospital
9456
mi
from 43215
St Leonards,
Click here to add this to my saved trials
Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds
Prospective Randomized Trial of Polymem vs. Bacitracin/Xeroform for Superficial Second Degree Burns
Status: Enrolling
Updated:  8/28/2017
MetroHealth Med Ctr
127
mi
from 43215
Cleveland, OH
Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds
Prospective Randomized Trial of Polymem vs. Bacitracin/Xeroform for Superficial Second Degree Burns
Status: Enrolling
Updated: 8/28/2017
MetroHealth Med Ctr
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated:  8/28/2017
University of New England College of Osteopathic Medicine
691
mi
from 43215
Biddeford, ME
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated: 8/28/2017
University of New England College of Osteopathic Medicine
691
mi
from 43215
Biddeford, ME
Click here to add this to my saved trials
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated:  8/28/2017
West Virginia School of Osteopathic Medicine
203
mi
from 43215
Lewisburg, WV
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated: 8/28/2017
West Virginia School of Osteopathic Medicine
203
mi
from 43215
Lewisburg, WV
Click here to add this to my saved trials
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
A Single-Dose, Randomized, Double-Blind, Placebo-Controlled Onset-of-Action Study Utilizing the Double-Stopwatch Method
Status: Enrolling
Updated:  8/30/2017
University of Connecticut - Student Health Services
576
mi
from 43215
Storrs, CT
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
A Single-Dose, Randomized, Double-Blind, Placebo-Controlled Onset-of-Action Study Utilizing the Double-Stopwatch Method
Status: Enrolling
Updated: 8/30/2017
University of Connecticut - Student Health Services
576
mi
from 43215
Storrs, CT
Click here to add this to my saved trials
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Status: Enrolling
Updated:  8/31/2017
Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Status: Enrolling
Updated: 8/31/2017
Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Indiana University
167
mi
from 43215
Indianapolis, IN
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Indiana University
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Iowa
461
mi
from 43215
Iowa City, IA
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Iowa
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
481
mi
from 43215
New York, NY
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated:  8/31/2017
4437
mi
from 43215
Alassio,
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated: 8/31/2017
4437
mi
from 43215
Alassio,
Click here to add this to my saved trials
Dysfunctional Hemoglobin Pulse Oximetry
Dysfunctional Hemoglobin Pulse Oximeter
Status: Enrolling
Updated:  8/31/2017
HPPL Duke Univeristy
352
mi
from 43215
Durham, NC
Dysfunctional Hemoglobin Pulse Oximetry
Dysfunctional Hemoglobin Pulse Oximeter
Status: Enrolling
Updated: 8/31/2017
HPPL Duke Univeristy
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
High-strength Glass-ionomer Dental Restorations
Clinical Performance of High-Viscous Glass-Ionomer Restorative Systems In Class II Lesions
Status: Enrolling
Updated:  9/5/2017
Mott Children's Health Center
213
mi
from 43215
Flint, MI
High-strength Glass-ionomer Dental Restorations
Clinical Performance of High-Viscous Glass-Ionomer Restorative Systems In Class II Lesions
Status: Enrolling
Updated: 9/5/2017
Mott Children's Health Center
213
mi
from 43215
Flint, MI
Click here to add this to my saved trials
Speech Perception for Children With Cochlear Implants
Speech Perception in Noise for Children With Cochlear Implants
Status: Enrolling
Updated:  9/7/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Speech Perception for Children With Cochlear Implants
Speech Perception in Noise for Children With Cochlear Implants
Status: Enrolling
Updated: 9/7/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated:  9/7/2017
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated: 9/7/2017
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated:  9/7/2017
Victoria Hospital
8572
mi
from 43215
Bangalore,
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated: 9/7/2017
Victoria Hospital
8572
mi
from 43215
Bangalore,
Click here to add this to my saved trials
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)
Status: Enrolling
Updated:  9/11/2017
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)
Status: Enrolling
Updated: 9/11/2017
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Cardiac Output Monitoring in Burn Patients
Non-invasive Cardiac Output Monitoring in Patients With Burn Injuries
Status: Enrolling
Updated:  9/11/2017
Grady Memorial Hospital
435
mi
from 43215
Atlanta, GA
Cardiac Output Monitoring in Burn Patients
Non-invasive Cardiac Output Monitoring in Patients With Burn Injuries
Status: Enrolling
Updated: 9/11/2017
Grady Memorial Hospital
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.
Status: Enrolling
Updated:  9/12/2017
Center for Environmental Medicine, Asthma and Lung Biology
344
mi
from 43215
Chapel Hill, NC
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.
Status: Enrolling
Updated: 9/12/2017
Center for Environmental Medicine, Asthma and Lung Biology
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Status: Enrolling
Updated:  9/13/2017
Nils Hasselmo Hall, 6-105
625
mi
from 43215
Minneapolis, MN
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Status: Enrolling
Updated: 9/13/2017
Nils Hasselmo Hall, 6-105
625
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials